In vivo oral toxicological evaluation of mesoporous silica particles

Nanomedicine

Volumn 8, Issue 1, 2013, Pages 57-64

  Kupferschmidt, Natalia ^a,b   Xia, Xin ^b,c   Labrador, Roberto H ^b   Atluri, Rambabu ^b   Ballell, Lluis ^d   Garcia Bennett, Alfonso E ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b NANOLOGICA AB   (Sweden)

^c STOCKHOLM UNIVERSITY   (Sweden)

^d Glaxo SmithKline   (Spain)

Author keywords

biovailability; mesoporous; oral administration; silica particle; toxicity

Indexed keywords

ANIONIC SURFACTANT; FOLIC ACID; MESOPOROUS SILICA; SILICON DIOXIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; FEMALE; IN VIVO STUDY; MALE; MAXIMUM TOLERATED DOSE; NANOTOXICOLOGY; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RAT; SCANNING ELECTRON MICROSCOPY; TOXICITY TESTING; X RAY POWDER DIFFRACTION;

EID: 84871604259     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.12.77     Document Type: Article

References (21)

1. De Jong WH, Borm PJA. Drug delivery and nanoparticles: Applications and hazards. Int. J. Nanomed. 3(2), 133-149 (2008
2. Garcia-Bennett AE. Synthesis, toxicology and potential of ordered mesoporous materials in nanomedicine. Nanomedicine (Lond.) 6(5), 867-877 (2011
3. Manzano M, Aina V, Arean CO et al. Studies on MCM-41 mesoporous silica for drug delivery: Effect of particle morphology and amine functionalization. Chem. Eng. J. 137(1), 30-37 (2008
4. Van Speybroeck M, Barillaro V, Do Thi T et al. Ordered mesoporous silica material SBA-15: A broad-spectrum formulation platform for poorly soluble drugs. J. Pharm. Sci. 98(8), 2648-2658 (2009
5. Xia X, Zhou C, Ballell L, Garcia-Bennett AE. In vivo enhancement in bioavailability of atazanavir in the presence of proton-pump inhibitors using mesoporous materials. ChemMedChem 7(1), 43-48 (2012
6. Fadeel B, Garcia-Bennett AE. Better safe than sorry: Understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications. Adv. Drug Deliv. Rev. 62(3), 362-374 (2010
7. Vallet-Regi M, Balas F, Arcos D. Mesoporous materials for drug delivery. Angew. Chem. Int. Edit. 46(40), 7548-7558 (2007
8. Lu J, Liong M, Li ZX, Zink JI, Tamanoi F. Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals. Small 6(16), 1794-1805 (2010
9. Witasp E, Kupferschmidt N, Bengtsson L et al. Efficient internalization of mesoporous silica particles of different sizes by primary human macrophages without impairment of macrophage clearance of apoptotic or antibody-opsonized target cells. Toxicol. Appl. Pharm. 239(3), 306-319 (2009
10. Hudson SP, Padera RF, Langer R, Kohane DS. The biocompatibility of mesoporous silicates. Biomaterials 29(30), 4045-4055 (2008
11. Liu TL, Li LL, Teng X et al. Single and repeated dose toxicity of mesoporous hollow silica nanoparticles in intravenously exposed mice. Biomaterials 32(6), 1657-1668 (2011
12. Mellaerts R, Aerts CA, Van Humbeeck J, Augustijns P, Van Den Mooter G, Martens JA. Enhanced release of itraconazole from ordered mesoporous SBA-15 silica materials. Chem. Commun. 13, 1375-1377 (2007
13. Mellaerts R, Mols R, Kayaert P et al. Ordered mesoporous silica induces pH-independent supersaturation of the basic low solubility compound itraconazole resulting in enhanced transepithelial transport. Int. J. Pharmaceut. 357(1-2), 169-179 (2008
14. Heikkilä T, Santos HA, Kumar N et al. Cytotoxicity study of ordered mesoporous silica MCM-41 and SBA-15 microparticles on Caco-2 cells. Eur. J. Pharm. Biopharm. 74(3), 483-494 (2010
15. Atluri R, Hedin N, Garcia-Bennett AE. Nonsurfactant supramolecular synthesis of ordered mesoporous silica. J. Am. Chem. Soc. 131(9), 3189-3191 (2009
16. Garcia-Bennett AE, Terasaki O, Che S, Tatsumi T. Structural investigations of AMS-n mesoporous materials by transmission electron microscopy. Chem. Mater. 16(5), 813-821 (2004
17. Klose D, Siepmann F, Elkharraz K, Krenzlin S, Siepmann J. How porosity and size affect the drug release mechanisms from PLIGA-based microparticles. Int. J. Pharmaceut. 314(2), 198-206 (2006
18. Kruk M, Jaroniec M. Gas adsorption characterization of ordered organic-inorganic nanocomposite materials. Chem. Mater. 13(10), 3169-3183 (2001
19. Damsch S, Eichenbaum G, Tonelli A et al. Gavage-related reflux in rats: Identification, pathogenesis, and toxicological implications (review). Toxicol. Pathol. 39(2), 348-360 (2011
20. Huang XL, Li LL, Liu TL et al. The shape effect of mesoporous silica nanoparticles on biodistribution, clearance, and biocompatibility in vivo. ACS Nano 5(7), 5390-5399 (2011
21. He QJ, Zhang ZW, Gao F, Li YP, Shi JL. In vivo biodistribution and urinary excretion of mesoporous silica nanoparticles: Effects of particle size and PEGylation. Small 7(2), 271-280 (2011